A Structure-based Approach to Retinoid X Receptor-α Inhibition*

In this paper we describe a structure-based approach designed to identify novel ligands for retinoid X receptor-α (RXRα). By using a virtual approach based on a modified scoring function, we have selected 200 potential candidates on the basis of their predicted ability of docking into the ligand-binding site of the target. Subsequent experimental verification of the compounds in in vitro and cell-based assays led to the identification of a number of novel high affinity ligands for RXRα. The compounds are capable of displacing 9-cis-retinoic acid with IC50 values in the 10 nm and 5 μm range and exhibit marked antagonistic activity in cellular assays. The inhibitory scaffolds discovered with this method form the basis for the development of novel RXRα ligands with potential therapeutic properties.

[1]  John Calvin Reed,et al.  Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells , 1996, Molecular and cellular biology.

[2]  M. Dawson,et al.  These include: , 1993 .

[3]  Philippe Kastner,et al.  Nonsteroid nuclear receptors: What Are genetic studies telling us about their role in real life? , 1995, Cell.

[4]  M Rarey,et al.  Detailed analysis of scoring functions for virtual screening. , 2001, Journal of medicinal chemistry.

[5]  J. Irwin,et al.  Lead discovery using molecular docking. , 2002, Current opinion in chemical biology.

[6]  R. Evans,et al.  The RXR heterodimers and orphan receptors , 1995, Cell.

[7]  M. Dawson Synthetic retinoids and their nuclear receptors. , 2004, Current medicinal chemistry. Anti-cancer agents.

[8]  J. Rao,et al.  Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer development. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[9]  A. Alonso,et al.  Inhibition of Yersinia Tyrosine Phosphatase by Furanyl Salicylate Compounds* , 2005, Journal of Biological Chemistry.

[10]  R. Chandraratna,et al.  Adenomatous Polyposis Coli (APC)-independent Regulation of β-Catenin Degradation via a Retinoid X Receptor-mediated Pathway* , 2003, Journal of Biological Chemistry.

[11]  R. Abagyan,et al.  Determinants of retinoid X receptor transcriptional antagonism. , 2004, Journal of medicinal chemistry.

[12]  H. Cottam,et al.  The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Dawoon Jung,et al.  Efficient synthetic inhibitors of anthrax lethal factor. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  X-k Zhang,et al.  Vitamin A and apoptosis in prostate cancer. , 2002, Endocrine-related cancer.

[15]  M. Pfahl,et al.  Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors , 1992, Nature.

[16]  Malcolm J. McGregor,et al.  Virtual Screening in Drug Discovery , 2006 .

[17]  A. Rishi,et al.  Antagonist analogue of 6-[3'-(1-adamantyl)-4'-hydroxyphenyl]-2-naphthalenecarboxylic acid (AHPN) family of apoptosis inducers that effectively blocks AHPN-induced apoptosis but not cell-cycle arrest. , 2004, Journal of medicinal chemistry.

[18]  P. Cohen,et al.  Rapid Apoptosis Induction by IGFBP-3 Involves an Insulin-like Growth Factor-independent Nucleomitochondrial Translocation of RXRα/Nur77* , 2005, Journal of Biological Chemistry.

[19]  Dawoon Jung,et al.  Discovery of a novel class of reversible non-peptide caspase inhibitors via a structure-based approach. , 2005, Journal of medicinal chemistry.

[20]  G. V. Paolini,et al.  Empirical scoring functions: I. The development of a fast empirical scoring function to estimate the binding affinity of ligands in receptor complexes , 1997, J. Comput. Aided Mol. Des..

[21]  John Calvin Reed,et al.  Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. , 2000, Science.

[22]  Gennady M Verkhivker,et al.  Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming. , 1995, Chemistry & biology.

[23]  P. Roy-Burman,et al.  Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium. , 2002, Cancer research.

[24]  Y. Li,et al.  Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids , 1997, Molecular and cellular biology.

[25]  V. Ferrans,et al.  Modulation of retinoid signalling through NGF-induced nuclear export of NGFI-B , 2000, Nature Cell Biology.

[26]  Dawoon Jung,et al.  Virtual docking approaches to protein kinase B inhibition. , 2005, Journal of medicinal chemistry.

[27]  Xiao-Kun Zhang,et al.  Regulation of retinoid and thyroid hormone action through homodimeric and heterodimeric receptors , 1993, Trends in Endocrinology & Metabolism.

[28]  T. Perlmann,et al.  Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. , 2000, Science.

[29]  Stephen W. Fesik,et al.  One-Dimensional Relaxation- and Diffusion-Edited NMR Methods for Screening Compounds That Bind to Macromolecules , 1997 .

[30]  Naisyin Wang,et al.  Chemopreventive n-3 fatty acids activate RXRα in colonocytes , 2003 .

[31]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.

[32]  H. DeLuca,et al.  Isolation and characterization of unsaturated fatty acids as natural ligands for the retinoid-X receptor. , 2003, Archives of biochemistry and biophysics.

[33]  J. Lehmann,et al.  Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid , 1992, Nature.

[34]  E. Jaeger,et al.  Comparison of automated docking programs as virtual screening tools. , 2005, Journal of Medicinal Chemistry.